Genomics

Dataset Information

0

Correction of a Factor VIII genomic inversion with designer recombinases


ABSTRACT: Despite advances in nuclease-based genome editing technologies, correcting human disease-causing genomic inversions remains a challenge. Here, we describe the potential use of a recombinase-based system to correct the 140 kb inversion of the F8 gene frequently found in patients diagnosed with severe Hemophilia A. Employing substrate-linked directed molecular evolution, we developed a coupled heterodimeric recombinase system (RecF8) achieving 30% inversion of the target sequence in human tissue culture cells. Transient RecF8 treatment of endothelial cells, differentiated from patient derived induced pluripotent stem cells (iPSCs) of a hemophilic donor, resulted in 12% correction of the inversion and restored Factor VIII mRNA expression. Our data suggests that designer-recombinases may represent efficient and specific means towards treatment of monogenic diseases caused by large gene inversions.

PROVIDER: EGAS00001005496 | EGA |

REPOSITORIES: EGA

Similar Datasets

2021-12-31 | GSE159492 | GEO
2010-06-25 | E-GEOD-16616 | biostudies-arrayexpress
2010-05-05 | E-GEOD-21607 | biostudies-arrayexpress
2010-12-06 | E-GEOD-15565 | biostudies-arrayexpress
2010-05-05 | GSE21607 | GEO
2010-12-06 | GSE15565 | GEO
2014-09-13 | E-GEOD-58650 | biostudies-arrayexpress
2014-09-13 | GSE58650 | GEO
2020-02-02 | GSE110210 | GEO
2020-02-02 | GSE110089 | GEO